Agios Pharmaceuticals, Inc. - Common Stock (NQ:AGIO)

43.65 +1.11 (+2.61%)

Streaming Delayed Price Updated: 4:00 PM EST, Nov 14, 2025 Add to My Watchlist

Price and Volume

Volume	848,753
Open	41.89
Bid (Size)	43.50 (100)
Ask (Size)	43.65 (100)
Prev. Close	42.54
Today's Range	41.34 - 44.29
52wk Range	23.41 - 62.45
Shares Outstanding	58,951,469
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Agios Pharmaceuticals Inc (NASDAQ:AGIO) Tops Q3 2025 Estimates with Strong Revenue Beat ↗

October 30, 2025

Agios Pharma's Q3 2025 results beat revenue and EPS estimates, driving a positive market reaction and highlighting strong commercial performance.

Via Chartmill

Earnings Scheduled For October 30, 2025 ↗

October 30, 2025

Via Benzinga

Performance

YTD	+37.1%	+37.1%
1 Month	+5.5%	+5.5%
3 Month	+17.9%	+17.9%
6 Month	+49.6%	+49.6%
1 Year	-21.2%	-21.2%

More News

Earnings Outlook For Agios Pharmaceuticals ↗

October 29, 2025

Via Benzinga

Inhibrx Stock Soars on Breakthrough Chondrosarcoma Trial Results: A New Dawn for Rare Cancer Treatment

October 24, 2025

Via MarketMinute

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Agios Pharmaceuticals, Inc. – AGIO

September 24, 2025

From Pomerantz LLP

Via GlobeNewswire

Agios Retail Buzz Surges On Saudi Thalassemia Nod As Retail Hails ‘Incredible Recovery’ Despite FDA Concerns ↗

August 05, 2025

Via Stocktwits

Earnings Scheduled For July 31, 2025 ↗

July 31, 2025

Via Benzinga

Earnings Scheduled For May 1, 2025 ↗

May 01, 2025

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

September 23, 2025

Via Benzinga

AGIO Investors Have Opportunity to Join Agios Pharmaceuticals, Inc. Fraud Investigation With the Schall Law Firm

September 15, 2025

From Schall Law Firm

Via Business Wire

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Agios Pharmaceuticals, Inc. – AGIO

September 14, 2025

From Pomerantz LLP

Via GlobeNewswire

An Overview of Agios Pharmaceuticals's Earnings ↗

April 30, 2025

Via Benzinga

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Agios Pharmaceuticals, Inc. – AGIO

September 10, 2025

From Pomerantz LLP

Via GlobeNewswire

Agios Pharma Stock Slumped 15% Today But Company Remains Top Pick For This Analyst – Find Out More ↗

September 04, 2025

Via Stocktwits

FDA Delays Decision On Agios Pharmaceuticals' Blood Disorder Drug For Expanded Use ↗

September 04, 2025

Via Benzinga

Top movers in Thursday's pre-market session ↗

September 04, 2025

Via Chartmill

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

September 04, 2025

Via Benzinga

10 Health Care Stocks With Whale Alerts In Today's Session ↗

August 21, 2025

Via Benzinga

12 Health Care Stocks Moving In Monday's Intraday Session ↗

August 04, 2025

Via Benzinga

Traders are paying attention to the gapping stocks in Monday's session. ↗

August 04, 2025

Via Chartmill

What's going on in today's pre-market session ↗

August 04, 2025

Via Chartmill

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

August 04, 2025

Via Benzinga

Agios (AGIO) Q2 Revenue Jumps 45% ↗

August 01, 2025

Via The Motley Fool

Agios Pharmaceuticals Inc (NASDAQ:AGIO) Reports Mixed Q2 2025 Results: Revenue Beat but Wider EPS Loss ↗

July 31, 2025

Via Chartmill

Agios Pharmaceuticals Reveals Encouraging Data From Rare Blood Disorder Study In Younger Patients Aged Below 18 Years ↗

February 13, 2025

Via Benzinga

Frequently Asked Questions

Is Agios Pharmaceuticals, Inc. - Common Stock publicly traded?

Yes, Agios Pharmaceuticals, Inc. - Common Stock is publicly traded.

What exchange does Agios Pharmaceuticals, Inc. - Common Stock trade on?

Agios Pharmaceuticals, Inc. - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for Agios Pharmaceuticals, Inc. - Common Stock?

The ticker symbol for Agios Pharmaceuticals, Inc. - Common Stock is AGIO on the Nasdaq Stock Market

What is the current price of Agios Pharmaceuticals, Inc. - Common Stock?

The current price of Agios Pharmaceuticals, Inc. - Common Stock is 43.65

When was Agios Pharmaceuticals, Inc. - Common Stock last traded?

The last trade of Agios Pharmaceuticals, Inc. - Common Stock was at 11/14/25 04:00 PM ET

What is the market capitalization of Agios Pharmaceuticals, Inc. - Common Stock?

The market capitalization of Agios Pharmaceuticals, Inc. - Common Stock is 2.57B

How many shares of Agios Pharmaceuticals, Inc. - Common Stock are outstanding?

Agios Pharmaceuticals, Inc. - Common Stock has 3B shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.